Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study
Titel:
Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study
Auteur:
Ciuleanu, Tudor Stelmakh, Lilia Cicenas, Saulius Miliauskas, Skaidrius Grigorescu, Alexandru Calin Hillenbach, Carina Johannsdottir, Hrefna Kristin Klughammer, Barbara Gonzalez, Emilio Esteban